Cambridge University gets go-ahead for new £22m Parkinson’s research centre

Advances

Author: Almaz OhenePublished: 11 November 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Cambridge Uni

A ‘state-of-the-art’ University of Cambridge chemistry facility, specialising in Parkinson’s disease research, is set to open in 2017

The world-renowned University of Cambridge has received the green light for plans to build a £22m chemistry facility, which will be its new headquarters for research into Parkinson’s disease, type 2 diabetes and Alzheimer’s disease.

The Chemistry of Health Centre will house a Chemistry of Health Incubator “with research scientists from industrial partners and start-ups occupying laboratory and desk space alongside academics from Cambridge and collaborating institutions,” according to minutes printed in the University Reporter weekly bulletin.

The report also stated that the research centre “will enable the Department of Chemistry’s Centre for Protein Misfolding Diseases to combat modern pandemics such as Parkinson’s disease”.

The building will also include a Molecular Production and Characterisation Centre, which will provide support and access to state-of-the-art instrumentation for academic and industry researchers from across the UK.

The building works are expected to begin in March 2016 and the centre is due to open in late 2017.

The estimated project cost of £22m will be met by a £17m grant from the Higher Education Funding Council for England and £5m in philanthropic donations.

Go Back

Share this story

Comments


Related articles


fight-parkinson-mockup

Perspectives

Parkinson’s website could put lives at risk, says clinical director of Parkinson’s UK

Claims made by Fight Parkinson’s are “absolutely unsubstantiated”

READ MORE
PL_Anicea and Larry

Perspectives

VIDEO: Watch Parkinson’s patient walk again after hearing favourite song

Viral video shows 73-year-old patient walk with help of song

READ MORE
Growth factors neurons

Resources & Tools

Parkinson’s podcast: Stopping disease progression – growth factors

Are growth factors still an effective disease-modifying strategy?

READ MORE